Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model

Micha Levi1, Delia A Dempsey, Neal L Benowitz

  • 1Department of Biopharmaceutical Sciences, School of Pharmacy, University of California San Francisco, San Francisco, CA 94143-1220, USA.

Journal of Pharmacokinetics and Pharmacodynamics
|January 9, 2007
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Compensatory Smoking With Very Low Nicotine Content Cigarettes: A Systematic Review and Meta-Analysis.

JAMA network open·2026
Same author

Cannabis Vaping, Smoking, and Dual Use and the Onset of Respiratory Symptoms Among U.S. Young Adults.

American journal of preventive medicine·2026
Same author

An evaluation of cytisinicline for smoking cessation in adult smokers.

Expert opinion on pharmacotherapy·2026
Same author

Beyond Cigarette Count: Nonlinear Cardiovascular Risk in Black Light Smokers.

Journal of the American Heart Association·2026
Same author

Titration of nicotine intake in smokers switching to reduced nicotine content cigarettes with access to alternative nicotine systems: Secondary analysis of a randomized clinical trial.

Addiction (Abingdon, England)·2026
Same author

Propensity score modeling of adolescent e-cigarette use and cognitive performance: One-year follow-up study.

Tobacco induced diseases·2026

Predicting nicotine clearance, a measure of CYP2A6 activity, using saliva cotinine and 3-hydroxycotinine is improved by modeling the log ratio of metabolites. This method offers better accuracy for clinical applications in smokers.

Area of Science:

  • Pharmacokinetics
  • Metabolism studies
  • Biomarker development

Background:

  • Nicotine (NIC) clearance reflects CYP2A6 enzyme activity, crucial for understanding smoking behavior and addiction.
  • Accurate prediction of individual NIC clearance is essential for personalized smoking cessation strategies.
  • Saliva cotinine (COT) and 3'-hydroxycotinine (3HC) are key metabolites used to assess NIC metabolism.

Purpose of the Study:

  • To develop and compare methods for predicting individual NIC clearance using saliva COT and 3HC.
  • To evaluate the precision, bias, and accuracy of different prediction models.
  • To assess the influence of smoking patterns on metabolite concentrations.

Main Methods:

  • Simulated saliva COT and 3HC concentrations using a population pharmacokinetic model of NIC metabolism.

Related Experiment Videos

  • Compared four methods: reference ratio model (M1), log-ratio model (M2), spline model (M3), and Bayesian estimate (M4).
  • Evaluated performance based on precision, bias, and fraction of predictions within 25% absolute error.

    • Main Results:

    • Methods M2-M4 demonstrated higher precision, accuracy, and a greater fraction of accurate predictions compared to M1.
    • The differences between M2 and M4 were minimal.
    • Smoking patterns did not significantly impact COT and 3HC concentration profiles.

    Conclusions:

    • An intercept slope model of the log ratio of 3HC to COT (M2) is a simple yet effective method for predicting NIC clearance.
    • Method M2 offers improved accuracy over direct metabolite ratio analysis.
    • This validated method supports the clinical estimation of CYP2A6 activity in smokers.